BRAF and lung adenocarcinoma: In a lung adenocarcinoma patient‐derived xenograft model and a cell line derived from the xenograft, BRAF G469V was the only known oncogenic mutation, and knockdown of BRAF and not EGFR killed the xenograft‐derived cell line.